Adma Biologics Inc share price logo

Adma Biologics Inc Share Price

NASDAQ: ADMA

Mid Cap

$15.30

-0.80

(-5.00%)

as on

Adma Biologics Inc Stock Performance

as on September 16, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $15.14
    $16.23
    downward going graph

    1.05%

    Downside

    6.08%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $13.5
    $25.67
    downward going graph

    11.76%

    Downside

    67.78%

    Upside

    downward going graph

Adma Biologics Inc share price movements today

Previous Close
$16.11
Open
$16.21
Volume
3.0M
Day's Low - High
$15.14 - $16.23
52 Week Low - High
$13.5 - $25.67

Adma Biologics Inc Historical Returns

1 Month Return
-5.18 %
3 Month Return
-22.59 %
1 Year Return
-10.95 %
3 Year Return
+ 494.46 %
5 Year Return
0 %

Adma Biologics Inc Stock Fundamentals & Key Indicators

Check Adma Biologics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.8B

EPS (TTM)

0.565

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.08%

PE Ratio (TTM)

18.95

Industry PE ratio

10.127857142857144

P/B Ratio

18.9529

PEG Ratio

0

EBITDA

163.6M

Revenue (TTM)

474.2M

Profit Margin

44.06%

Return On Equity TTM

71.23%

Adma Biologics Inc Stock Valuation

Track how Adma Biologics Inc P/E has moved over time to understand its valuation trends.

Adma Biologics Inc in the last 5 years

  • Overview

  • Trends

Lowest (32.88x)

March 31, 2025

Industry (10.13x)

September 15, 2025

Today (18.95x)

September 15, 2025

Highest (59.92x)

June 30, 2024

LowHigh

Today’s Price to Earnings Ratio: 18.95x

Adma Biologics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Adma Biologics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$3.8BNA18.9544.06%
BUY$61.1B256.98%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$101.1B47.85%28.0731.86%
BUY$59.4B-3.43%14.1131.37%

Stock Returns calculator for Adma Biologics Inc Stock including INR - Dollar returns

The Adma Biologics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Adma Biologics Inc investment value today

Current value as on today

₹89,562

Returns

₹10,438

(-10.44%)

Returns from Adma Biologics Inc Stock

₹15,423 (-15.42%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Adma Biologics Inc Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Adma Biologics Inc. Average target price of $29.06

Adma Biologics Inc Share Price Target

Get share price movements and forecasts by analysts on Adma Biologics Inc.

What analysts predicted

47.35%UPSIDE

Target Price

$29.06

Current Price

$15.3

Analyzed by

10 Analysts

Target

$29.06

Adma Biologics Inc target price $29.06, a slight upside of 47.35% compared to current price of $15.3. According to 10 analysts rating.

Adma Biologics Inc Stock's Interest Amongst Investors

Investment in Adma Biologics Inc Shares on INDmoney has dropped by -42.85% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-42.85% versus previous 30 day period

Search interest for Adma Biologics Inc Stock has decreased by -9% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-9% versus previous 30 day period

Adma Biologics Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
56
60
67
73
81
107
119
117
114
121
Gross Profit
16
16
24
30
38
57
59
63
61
67
Operating Income
0
0
8
14
21
39
39
38
34
42
EBITDA
1
2
11
-9
23
41
42
39
37
43
Interest Expense
6
6
6
6
3
3
3
2
1
1
Depreciation
0
2
2
2
2
2
1
1
1
2
Income Before Tax
-6
-6
2
-17
18
35
36
34
33
40
Income Tax Expense
5
6
6
0
0
3
0
-77
6
5
Net Income
-12
-6
2
-17
17
32
35
111
26
34
Net Profit Margin
-22.43%
-10.60%
3.81%
-23.88%
21.75%
29.91%
29.96%
95.19%
23.44%
28.05%

Adma Biologics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
7
10
22
16
29
42
80
154
258
426
Gross Profit
2
4
-6
-25
-10
-19
1
35
88
219
Operating Income
-15
-17
-39
-60
-41
-64
-58
-39
21
138
EBITDA
-15
-16
-39
-56
-36
-59
-53
-39
5
147
Interest Expense
1
2
3
5
8
11
13
19
25
13
Depreciation
-
-
2
3
3
3
5
7
8
8
Income Before Tax
-17
-19
-43
-65
-48
-75
-71
-65
-28
125
Income Tax Expense
2
2
4
5
8
11
12
19
8
-71
Net Income
-17
-19
-43
-65
-57
-87
-84
-85
-28
197
Net Profit Margin
-250.36%
-183.05%
-192.26%
-387.06%
-194.37%
-207.50%
-104.34%
-55.29%
-10.94%
46.35%

Adma Biologics Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-6
2
-17
17
32
35
111
26
34
Operating Cash Flow
-6
11
17
-2
45
25
50
-19
21
Investing Cash Flow
0
0
-1
-2
-2
-1
-2
-4
-2
Financing Cash Flow
0
0
-38
-1
0
-25
-31
-7
0
Change in Cash
-6
11
-22
-6
42
-1
16
-31
18

Adma Biologics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-19
-43
-65
-48
-75
-71
-65
-28
197
Operating Cash Flow
-18
-37
-62
-76
-102
-112
-59
8
118
Investing Cash Flow
0
15
-2
-3
-12
-13
-13
-4
-8
Financing Cash Flow
16
60
42
80
143
121
108
-38
-58
Change in Cash
0
38
-21
0
29
-4
35
-35
51

Global Institutional Holdings in Adma Biologics Inc

Funds
Holdings
BlackRock Inc
15.63%
Vanguard Group Inc
7.06%
Amvescap Plc.
5.39%
State Street Corp
4.8%
Geode Capital Management, LLC
2.38%

Insights on Adma Biologics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 26.90M → 34.21M (in $), with an average increase of 21.4% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 114.80M → 121.98M (in $), with an average increase of 5.9% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ADMA has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 86.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, ADMA stock has moved down by -22.6%

About Adma Biologics Inc

adma is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of primary immune deficiency disease (pidd) and certain infectious diseases. adma's mission is to develop and commercialize plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases. the target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease, or who may be immune-compromised for medical reasons. adma’s lead product candidate, ri-002, has completed a phase iii clinical trial in patients with pidd and has met the primary endpoint. a bla for ri-002 was accepted by the fda on september 18, 2015. the company has received u.s. patent 9,107,906. for more information, please visit the company's website at www.admabiologics.com.
OrganisationAdma Biologics Inc
Headquarters465 State Route 17, Ramsey, NJ, United States, 07446
IndustryHealth Technology
CEOMr. Adam S. Grossman
E-voting on sharesClick here to vote

Key Management of Adma Biologics Inc

Name

Title

Mr. Adam S. Grossman

Co-Founder, President, CEO & Director

Dr. Jerrold B. Grossman D.P.S., Ph.D.

Co-Founder & Vice Chairman of the Board

Mr. Brad Tade

CFO & Treasurer

Ms. Kaitlin Kestenberg

COO & Senior VP of Compliance

Mr. Michael Goldstein

General Counsel

Mr. John Hafl

Executive Director of Sales

Ms. Cindy Petersen

Vice President of Human Resources

Mr. Skyler Bloom

Senior Director of Business Development & Corporate Strategy

FAQs

What is Adma Biologics Inc share price today?

Adma Biologics Inc share price today is $15.3 as on at the close of the market. Adma Biologics Inc share today touched a day high of $16.23 and a low of $15.14.

What is the 52 week high and 52 week low for Adma Biologics Inc share?

Adma Biologics Inc share touched a 52 week high of $25.67 on and a 52 week low of $13.5 on . Adma Biologics Inc stock price today i.e. is closed at $15.3,which is 40.40% down from its 52 week high and 13.33% up from its 52 week low.

What is Adma Biologics Inc's market capitalisation today?

Adma Biologics Inc market capitalisation is $0.00T as on .

How to invest in Adma Biologics Inc Stock (ADMA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Adma Biologics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Adma Biologics Inc Shares that will get you 0.0980 shares as per Adma Biologics Inc share price of $15.3 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Adma Biologics Inc Stock (ADMA) from India?

Indian investors can start investing in Adma Biologics Inc (ADMA) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Adma Biologics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Adma Biologics Inc share’s latest price of $15.3 as on September 16, 2025 at 1:29 am IST, you will get 0.6536 shares of Adma Biologics Inc. Learn more about fractional shares .